Telehealth company Lucid Lane raised $16 million in Series A funding to continue developing its platform that enables real-time intervention for people with medication dependence and substance-use disorders.
Adnan Asar, co-founder and CEO of Lucid Lane, started the company five years ago after watching his wife struggle to stop taking medication she was prescribed following an illness.
There are 40 million people prescribed opioids and benzodiazepines each year, many like Asar’s wife, after surgery or in conjunction with cancer treatment to address acute and chronic pain as well as co-occurring mental health challenges, he told TechCrunch.
However, though the medications work well, out of the number of people prescribed,